Skip to content
healthcare.dev
Get a free key

Uroxatral

NDC 59212-200, Alfuzosin HCl, tablet, extended release, from Advanz Pharma (US) Corp..

Product NDC
59212-200
Status
Listed
Labeler
Advanz Pharma (US) Corp.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021287
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59212-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALFUZOSIN HYDROCHLORIDE10 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
59212-200-1059212020010100 TABLET, EXTENDED RELEASE in 1 BOTTLE (59212-200-10)
59212-200-305921202003030 TABLET, EXTENDED RELEASE in 1 BOTTLE (59212-200-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9fc7f119-f36b-44cf-945d-940160f3afe3

Use it

Look up 59212-200 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59212-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59212-200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.